References
- Welgampola MS, Colebatch JG. Characteristics and clinical applications of vestibular-evoked myogenic potentials. Neurology 2005; 64: 1682–8
- Zhou G, Cox LC. Vestibular evoked myogenic potentials: history and overview. Am J Audiol 2004; 13: 135–43
- Suzuki C, Ozaki I, Tanosaki M, Suda T, Baba M, Matsunaga M. Peripheral and central conduction abnormalities in diabetes mellitus. Neurology 2000; 54: 1932–7
- Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pach JM, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993; 43: 817–24
- Algan M, Ziegler O, Gehin P, Got I, Raspiller A, Weber M, et al. Visual evoked potentials in diabetic patients. Diabetes Care 1989; 12: 227–9
- Niedzielska G, Katska E. ABR disturbances in children with insulin dependent diabetes mellitus. Int J Pediatr Otorhinolaryngol 1998; 44: 1–4
- England JD, Gronseth GS, Franklin G, Miller RG, Asbury AK, Carter GT, et al. Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2005; 64: 199–207
- Perez R, Ziv E, Freeman S, Sichel JY, Sohmer H. Vestibular end-organ impairment in an animal model of type 2 diabetes mellitus. Laryngoscope 2001; 111: 110–13
- Proctor CA. Abnormal insulin levels and vertigo. Laryngoscope 1981; 91: 1657–62
- Rybak LP. Metabolic disorders of the vestibular system. Otolaryngol Head Neck Surg 1995; 112: 128–32
- Mangabeira Albernaz PL, Fukuda Y. Glucose, insulin and inner ear pathology. Acta Otolaryngol (Stockh) 1984; 97: 496–501
- Lehrer JF, Poole DC, Seaman M, Restivo D, Hartman K. Identification and treatment of metabolic abnormalities in patients with vertigo. Arch Intern Med 1986; 146: 1497–500
- Gawron W, Pospiech L, Orendorz-Fraczkowska K, Noczynska A. Are there any disturbances in vestibular organ of children and young adults with Type I diabetes?. Diabetologia 2002; 45: 728–34
- Schieppati M, Nardone A. Group II spindle afferent fibers in humans: their possible role in the reflex control of stance. Prog Brain Res 1999; 123: 461–72
- Nardone A, Schieppati M. Group II spindle fibres and afferent control of stance. Clues from diabetic neuropathy. Clin Neurophysiol 2004; 115: 779–89
- Di Nardo W, Ghirlanda G, Cercone S, Pitocco D, Soponara C, Cosenza A, et al. The use of dynamic posturography to detect neurosensorial disorder in IDDM without clinical neuropathy. J Diabetes Complications 1999; 13: 79–85
- Biurrun O, Ferrer JP, Lorente J, de Espana R, Gomis R, Traserra J. Asymptomatic electronystagmographic abnormalities in patients with type I diabetes mellitus. ORL J Otorhinolaryngol Relat Spec 1991; 53: 335–8
- Di Leo MA, Di Nardo W, Cercone S, Ciervo A, Lo MM, Greco AV, et al. Cochlear dysfunction in IDDM patients with subclinical peripheral neuropathy. Diabetes Care 1997; 20: 824–8
- Shojaku H, Takemori S, Kobayashi K, Watanabe Y. Clinical usefulness of glycerol vestibular-evoked myogenic potentials: preliminary report. Acta Otolaryngol Suppl 2001; 545: 65–8
- Brantberg K, Bergenius J, Tribukait A. Vestibular-evoked myogenic potentials in patients with dehiscence of the superior semicircular canal. Acta Otolaryngol (Stockh) 1999; 119: 633–40
- Colebatch JG, Rothwell JC, Bronstein A, Ludman H. Click-evoked vestibular activation in the Tullio phenomenon. J Neurol Neurosurg Psychiatry 1994; 57: 1538–40
- Murofushi T, Matsuzaki M, Mizuno M. Vestibular evoked myogenic potentials in patients with acoustic neuromas. Arch Otolaryngol Head Neck Surg 1998; 124: 509–12
- Matsuzaki M, Murofushi T, Mizuno M. Vestibular evoked myogenic potentials in acoustic tumor patients with normal auditory brainstem responses. Eur Arch Otorhinolaryngol 1999; 256: 1–4
- Halmagyi GM, Aw ST, Karlberg M, Curthoys IS, Todd MJ. Inferior vestibular neuritis. Ann N Y Acad Sci 2002; 956: 306–13